Interventional, Randomised, Double-blind, Study to Evaluate the Safety and Tolerability of Once Daily Versus Twice Daily Memantine Treatment in Patients With Dementia of Alzheimer's Type and MMSE Range 5 - 18
Phase of Trial: Phase IV
Latest Information Update: 29 Jul 2016
At a glance
- Drugs Memantine (Primary)
- Indications Alzheimer's disease; Dementia
- Focus Adverse reactions
- Sponsors Lundbeck A/S
- 26 Jul 2016 Status changed from recruiting to completed.
- 23 Oct 2015 Status changed from not yet recruiting to recruiting, as reported by ClinicalTrials.gov.
- 09 Oct 2015 Planned initiation date changed from 1 Sep 2015 to 1 Oct 2015, as reported by ClinicalTrials.gov.